creating crypto Top Knowledge graph

How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.It is reported that Blackstone Group may withdraw from its bid for Bausch & Lomb, an eye care company. People familiar with the matter said that Blackstone Group may withdraw from its joint bid for Bausch & Lomb. Earlier, it was reported that Blackstone and TPG (Detai Capital) jointly bid for Bausch & Lomb, an eye care company. At present, negotiations are still in progress. If Bausch & Lomb is willing to accept a lower price, or TPG finds another private equity investment group as a trading partner, the transaction may still be completed.The Hang Seng Index of Hong Kong stocks opened higher by 0.46%, the index of state-owned enterprises rose by 0.51%, and the branch index rose by 0.46%.

Shanghai's state-owned assets reform concept stocks rose to the daily limit, and Shanghai Material Trade, First Medicine, Shibei High-tech, Kaikai Industry and Shanghai 900 set an international daily limit.The decline of treasury bond futures expanded, with the 30-year main contract falling by 0.50%, the 30-year main contract falling by 0.50%, the 10-year main contract falling by 0.18%, the 5-year main contract falling by 0.12% and the 2-year main contract falling by 0.05%.Low-priced stocks were active repeatedly, and Mei Yan walked out of four boards in five days. In addition, more than 20 constituent stocks such as Pingtan Development, Smart Agriculture, Jin Zhengda, Zhongnan, Xiamen Industrial Co., Ltd. and Yabo Co., Ltd. had daily limit.

Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.The newly established technology companies such as Doushen Education include a number of AI businesses. The enterprise search APP shows that recently, Shenzhen Doushen Bilingual Times Technology Co., Ltd. was established, with Hu Xiaokang as the legal representative and a registered capital of 1 million yuan. Its business scope includes artificial intelligence application software development, artificial intelligence basic resources and technology platform, artificial intelligence basic software development, artificial intelligence general application system and artificial intelligence hardware sales. Enterprise investigation shows that the company is jointly owned by Doushen Times Technology Development (Beijing) Co., Ltd. and Shenzhen Heyun Education Technology Co., Ltd., a subsidiary of Doushen Education.